page contents
 

adhdGraphicRemake

References

Krull R, Brouwers P, Jain N et al. Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr 2008;152:101-105.

Schlotz W, Jones A, Phillips D et al. Lower maternal folate status in early pregnancy is associated with childhood hyperactivity and peer problems in offspring. J Child Psychol Psychiatry 2010;51:594-602.

Selek S. Savas H, Gergerlioglu H et al. Oxidative imbalance in adult attention deficit/hyperactivity disorder. Biol Psychol 2008;79:256-259.

Dvorakova M, Sivonova M, Trebaticka J et al. The effect of polyphenolic extract from pine bark, Pycnogenol on the level of glutathione in children suffering from attention deficit hyperactivity disorder (ADHD). Redox Rep 2008;11:163-172.

Spahis S, Vanasse M, Belanger S et al. Lipid profile, fatty acid composition and pro- and anti-oxidant status in pediatric patients with attention-deficit/hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2008;79:47-53.

Bulut M, Selek S, Gergerlioglu H et al. Malondialdehyde levels in adult attention-deficit hyperactivity disorder. J Psychiatry Neurosci 2007;32:435-438.

Coleman M, Steinberg J, Tippett J et al. A preliminary study of the effect of pyridoxine administration in a subgroup of hyperkinetic children: a double-blind crossover comparison with methylphenidate. Biol Psychiatry 1979;14:741-751.

Mousain-Bosc M, Roche M, Polge A et al. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. I. Attention deficit hyperactivity disorders. Magnes Res 2006;19:46-52.

Mousain-Bosc M, Roche M, Rapin J et al. Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J Am Coll Nutr 2004;23:545S-548S.

Huss M, Volp A, Stauss-Grabo M. Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems – an observational cohort study. Lipids Health Dis 2010;9:105.

Arnold L, DiSilvestro R. Zinc in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2005;15:619-627.

Yorbik O, Ozdag M, Olgun A et al. Potential effects of zinc on information processing in boys with attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:662-667.

Arnold L, Pinkham S, Votolato N. Does zinc moderate essential fatty acid and amphetamine treatment of attention-deficit/hyperactivity disorder? J Child Adolesc Pychopharmacol 2000;10:111-117.

Dodig-Curkovic K, Dovhanj J, Curkovic M et al. The role of zinc in the treatment of hyperactivity disorder in children. Acta Med Croatica 2009;63:307-313.

Arnold L, Amato A, Bozzolo H et al. Acetyl-L-carnitine (ALC) in attention-deficit/hyperactivity disorder: a multi-site, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol 2007;17:791-802.

Van Oudheusden L. Scholte H. Efficacy of carntine in the treatment o children with attention-deficit hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids 2002;67:33-38.

Torrioli M, Vernacotola S, Peruzzi L et al. A double-blind, parallel, multicenter comparison of L-acetylcarnitine with placebo on the attention deficit hyperactivity disorder in fragile X syndrome boys. Am J Med Genet 2008;146:803.812.

Kidd P. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids. Altern Med Rev 2007;12:207-227.

Vaisman N, Kaysar N, Zaruk-Adasha Y et al. Correlation between changes in blood fatty acid composition and visual sustained attention performance in children with inattention: effect of dietary n-3 fatty acids containing phospholipids. Am J Clin Nutr 2008;87:1170-1180.

Pellow J, Solomon E, Barnard C. Complementary and alternative medical therapies for children with attention-deficit/hyperactivity disorder (ADHD). Altern Med Rev 2011;16:323-337.

Perlov E, Philipsen A, Hesslinger B et al. Reduced cingulated glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder – a magnetic resonance spectroscopy study. J Psychiatr Res 2007;41:934-941.

Carrey N, MacMaster F, Gaudet L et al. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 2007;17:11-17.

Rusch N, Boeker M, Buchert M et al. Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. World J Biol Psychiatry 2010;11:372-381.

Barth V, Need A, Tzavara E et al. In vivo occupancy of dopamine d3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder. J Pharmacol Exp Ther 2013;344:501-510

English B, Hahn M, Gizer I et al. Choline transporter gene variation is associated with attention-deficit hyperactivity disorder. J Neurodev Disord 2009;1:252-263.

Kronenberg G, Ende G, Alm B et al. Increased NAA and reduced choline levels in the anterior cingulum following chronic methylphenidate. A spectroscopic test-retest study in adult ADHD. Eur Arch Psychiatry Clin Neurosci 2008;258:446-450.

Additional references at http://www.spectracell.com/online-library-mnt-adhd-abstracts/